Education
About Us
Working with TipRanks
Follow Us
Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -185.00K |
| Operating Income | $ -158.83M | $ -114.36M | $ -71.66M | $ -43.22M | $ -17.19M |
| EBITDA | $ -156.54M | $ -112.63M | $ -71.12M | $ -42.94M | $ -17.01M |
| Net Income | $ -133.81M | $ -100.16M | $ -67.64M | $ -42.81M | $ -17.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 470.17M | $ 318.39M | $ 351.95M | $ 280.79M | $ 129.09M |
| Total Assets | $ 486.82M | $ 340.04M | $ 367.10M | $ 285.23M | $ 131.14M |
| Total Debt | $ 4.74M | $ 5.41M | $ 4.41M | $ 0.00 | $ 160.21M |
| Net Debt | $ -36.93M | $ -80.68M | $ -17.59M | $ -15.57M | $ 55.30M |
| Total Liabilities | $ 27.60M | $ 21.20M | $ 20.39M | $ 10.85M | $ 164.56M |
| Stockholders' Equity | $ 459.22M | $ 318.83M | $ 346.72M | $ 274.38M | $ -33.42M |
| Cash Flow | |||||
| Free Cash Flow | $ -110.34M | $ -97.69M | $ -58.18M | $ -34.17M | $ -14.84M |
| Operating Cash Flow | $ -109.03M | $ -91.95M | $ -52.63M | $ -33.51M | $ -14.63M |
| Investing Cash Flow | $ -184.66M | $ 102.89M | $ -70.58M | $ -242.23M | $ -24.38M |
| Financing Cash Flow | $ 249.25M | $ 53.17M | $ 129.64M | $ 186.38M | $ 120.28M |